Ambrisentan Rems Enrollment Form

Ambrisentan Rems Enrollment Form - You will need to provide the following Your insurance information Your signature on the form If you are a female in order to receive Letairis you must also enroll in a Risk Evaluation and Mitigation Strategy REMS program due to the risk of serious birth defects

To enroll in the Ambrisentan REMS complete and fax this form to 1 866 750 9802 Due to the risk of embryo fetal toxicity ambrisentan is available only through a restricted program called the Ambrisentan REMS Risk Evaluation and Mitigation Strategy

Ambrisentan Rems Enrollment Form

Ambrisentan Rems Enrollment Form

Indication Ambrisentan is an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability and delay clinical worsening.

Step 1 Complete the REMS Patient Enrollment and Consent Form for ALL female patients All female patients MUST complete the Patient Enrollment and Consent Form to enroll in the REMS Program prior to receiving treatment with Letairis Step 2 Complete the optional Letairis Prescription and LEAP Patient Support Enrollment Form

Span Class Result Type

Prescribers Click here to learn how to prescribe ambrisentan To prescribe ambrisentan 1 Review the Prescribing Information and Prescriber and Pharmacy Guide 2 Enroll in the REMS by completing the Prescriber Enrollment Form and submitting it to the Ambrisentan REMS 3

Spravato Rems Patient Enrollment Form Enrollment Form

To enroll in the Ambrisentan REMS complete and fax this form to 1 866 750 9802 or complete and submit online at ambrisentanrems us Due to the risk of embryo fetal toxicity ambrisentan is available only through a restricted program called the Ambrisentan REMS Risk Evaluation and Mitigation Strategy

Starting On Letairis Letairis Ambrisentan

Ambrisentan is a prescription medicine used to treat pulmonary arterial hypertension PAH which is high blood pressure in the arteries of your lungs Ambrisentan can improve your ability to exercise and it can help slow down the worsening of your physical condition and symptoms What are the serious risks of Ambrisentan

Ambrisentan Zydus Pharmaceuticals USA Inc FDA Package Insert

Section 505 1 i 1 C of the Federal Food Drug and Cosmetic Act FD C Act states that a generic drug e g ambrisentan is subject to certain elements of the REMS required for the

Required forms for Letairis® (ambrisentan): This medication has REMS requirements. REMS, or Risk Evaluation and Mitigation Strategy, requirements are put in place to ensure the safe use of certain medications with known risks. ... Generic Prescription Enrollment Form; Brand Prescription Enrollment Form; Getting your patient started on PAH ...

Span Class Result Type

Adult dosage Initiate Letairis 5 mg once daily with or without tadalafil 20 mg once daily At 4 week intervals consider either increasing to Letairis 10 mg or tadalafil 40 mg Do not split crush or chew tablets Pregnancy testing Initiate Letairis in females of reproductive potential only after a negative pregnancy test Obtain monthly

Ambrisentan Rems Enrollment Form

Section 505 1 i 1 C of the Federal Food Drug and Cosmetic Act FD C Act states that a generic drug e g ambrisentan is subject to certain elements of the REMS required for the

To enroll in the Ambrisentan REMS complete and fax this form to 1 866 750 9802 Due to the risk of embryo fetal toxicity ambrisentan is available only through a restricted program called the Ambrisentan REMS Risk Evaluation and Mitigation Strategy

Fillable Online SPRAVATO REMS Patient Enrollment Form Fax Email Print PdfFiller